Guest guest Posted November 26, 2010 Report Posted November 26, 2010 http://www.thepsychologist.org.uk/archive/archive_home.cfm?volumeID=22 & editionID\ =171 & ArticleID=1452 By Selwyn, Tooting London 'The Psychologist' 2009 The autism `trip' – a lifetime of altered perception? Following my son's diagnosis of autism some years ago, I have developed a theory that I would like to share with readers and ask whether anyone has any related evidence or would like to seek some. I published a paper on my theory with the National Autistic Society, and delivered it at the NHS research conference Experimental Biology and the Autistic Syndromes at Sunderland University. Many behavioural characteristics typical of autism closely parallel the effects of psychoactive compounds such as LSD and mescaline. I believe that if one were to be in a permanent state of altered perception, such as would be the case if the brain was spontaneously producing an endogenous psychoactive compound, you would effectively get the autistic state, which was why I called the paper `The Trip of a Lifetime'. One of the most common findings in the biochemical makeup of autistic children is the presence of high levels of bufotenin. Bufotenin is a minor metabolite of tryptophan, the amino acid precursor of the neurotransmitter serotonin. Another reason to suspect bufotenin is that the tryptophan molecule's structure is `indole'; it is the only amino acid in the body to be so and shares this characteristic with psychoactive compounds such as LSD and mescaline. It is, if you like, the common `link' between the two states. Bufotenin levels are normally held in balance by monoamine oxidase (MAO). If, however, MAO was inhibited, bufotenin levels could rise to a point where concentrations become such that behaviour is affected and the subject effectively begins to `trip'. This idea seems to be supported by recent research, published in New Scientist, carried out by Dr Ira Cohen, a psychologist at New York's State Institute for Basic Research in New York. Dr Cohen's research team has identified a relationship between the more severely affected autistic boys in their control group and a variation in the length of a control region at the start of the MAO gene. The variation determines how much of the enzyme is produced. Dr Cohen's work also seems to support the prevalence of autism in males, inasmuch as boys have only one copy of the gene, because it is only found on the X chromosome, while females of course have two. In summary I believe that we should be doing studies to confirm the presence of bufotenin in both the autistic child and in their parents – this would be relatively simple because it's detectable in urine – and then perhaps developing a drug to block bufotenin receptor sites in the brain. Selwyn Tooting London SW17 Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.